@aga-gastro.bsky.social
🌟 The December Editor's Essential Reading is the AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe #CrohnsDisease. Learn more at ow.ly/h9RH50XwU8c
November 24, 2025 at 6:41 PM
🌟 The December Editor's Essential Reading is the AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe #CrohnsDisease. Learn more at ow.ly/h9RH50XwU8c
📖 The December issue of #Gastroenterology is now online! It contains an AGA Clinical Practice Guideline, two Clinical Practice Updates and recommendations from the AGA Quality Committee. Click here to view the issue: ow.ly/J4gh50Xv7Zh
November 21, 2025 at 6:27 PM
📖 The December issue of #Gastroenterology is now online! It contains an AGA Clinical Practice Guideline, two Clinical Practice Updates and recommendations from the AGA Quality Committee. Click here to view the issue: ow.ly/J4gh50Xv7Zh
This #CDiffAwarenessMonth, read about how dietary fiber modulates the window of susceptibility to clostridioides difficile infection ➡️ ow.ly/84c350XtMLs
November 20, 2025 at 9:14 PM
This #CDiffAwarenessMonth, read about how dietary fiber modulates the window of susceptibility to clostridioides difficile infection ➡️ ow.ly/84c350XtMLs
📸 Gastro Curbside Consult presents a rare cause of abdominal pain and melena. Can you solve the diagnosis? Click the link to read more about this case: ow.ly/CCp650XsU7h
November 19, 2025 at 6:47 PM
📸 Gastro Curbside Consult presents a rare cause of abdominal pain and melena. Can you solve the diagnosis? Click the link to read more about this case: ow.ly/CCp650XsU7h
Nearly half (49%) of individuals completed a colonoscopy within 6 months of abnormal blood-based CRC screening—similar to stool-based testing. Timely follow-up is critical!
🔗 ow.ly/FizO50XsTzK
🔗 ow.ly/FizO50XsTzK
November 17, 2025 at 5:39 PM
Nearly half (49%) of individuals completed a colonoscopy within 6 months of abnormal blood-based CRC screening—similar to stool-based testing. Timely follow-up is critical!
🔗 ow.ly/FizO50XsTzK
🔗 ow.ly/FizO50XsTzK
Study examines an international consensus on appropriate management of corticosteroids in clinical trials in #IBD. Want to learn more? Click the link: ow.ly/Sat650XpsRG
November 12, 2025 at 5:30 PM
Study examines an international consensus on appropriate management of corticosteroids in clinical trials in #IBD. Want to learn more? Click the link: ow.ly/Sat650XpsRG
🆕 AGA Clinical Practice Guideline on Surveillance of Barrett’s Esophagus was published in the November issue of #Gastroenterology. Click the link below to read it!
🔗 ow.ly/bmCl50XpsmY
🔗 ow.ly/bmCl50XpsmY
November 10, 2025 at 5:48 PM
🆕 AGA Clinical Practice Guideline on Surveillance of Barrett’s Esophagus was published in the November issue of #Gastroenterology. Click the link below to read it!
🔗 ow.ly/bmCl50XpsmY
🔗 ow.ly/bmCl50XpsmY
New meta-analysis of 55 RCTs shows GLP-1RAs increase the risk of gallstones and acid reflux—but not other serious GI or biliary events.
🔗 ow.ly/zwew50XlXqc
🔗 ow.ly/zwew50XlXqc
November 7, 2025 at 5:49 PM
New meta-analysis of 55 RCTs shows GLP-1RAs increase the risk of gallstones and acid reflux—but not other serious GI or biliary events.
🔗 ow.ly/zwew50XlXqc
🔗 ow.ly/zwew50XlXqc
🔥 Hot paper from junior investigators evaluates blood-based T-cell diagnosis of #CeliacDisease. Read the full article here: ow.ly/NJJ050XlWYK
November 3, 2025 at 5:43 PM
🔥 Hot paper from junior investigators evaluates blood-based T-cell diagnosis of #CeliacDisease. Read the full article here: ow.ly/NJJ050XlWYK
On the final day of #LiverAwarenessMonth, we're highlighting a study that conducted a longitudinal evaluation of individuals with severe alpha-1 antitrypsin deficiency (Pi∗ZZ genotype.
Read the article here:
🔗 ow.ly/qTo350XiqLB
Read the article here:
🔗 ow.ly/qTo350XiqLB
October 31, 2025 at 4:54 PM
On the final day of #LiverAwarenessMonth, we're highlighting a study that conducted a longitudinal evaluation of individuals with severe alpha-1 antitrypsin deficiency (Pi∗ZZ genotype.
Read the article here:
🔗 ow.ly/qTo350XiqLB
Read the article here:
🔗 ow.ly/qTo350XiqLB
⭐ Randomized controlled trial compares #BarrettsOesophagus surveillance versus endoscopy at need study. Click the link to learn more: ow.ly/k4Sf50Xisbm
October 29, 2025 at 4:59 PM
⭐ Randomized controlled trial compares #BarrettsOesophagus surveillance versus endoscopy at need study. Click the link to learn more: ow.ly/k4Sf50Xisbm
✨ Review examines genetic risk assessment and testing for gastrointestinal cancers and polyposis in gastroenterology.
🔗 ow.ly/9rcC50Xf7oQ
🔗 ow.ly/9rcC50Xf7oQ
October 27, 2025 at 4:31 PM
✨ Review examines genetic risk assessment and testing for gastrointestinal cancers and polyposis in gastroenterology.
🔗 ow.ly/9rcC50Xf7oQ
🔗 ow.ly/9rcC50Xf7oQ
This #LiverAwarenessMonth, check out this article on the phase 3 biomarker validation of GALAD for the detection of #HepatocellularCarcinoma in #Cirrhosis ⬇️
ow.ly/h6YJ50XfeEk
ow.ly/h6YJ50XfeEk
October 24, 2025 at 6:11 PM
This #LiverAwarenessMonth, check out this article on the phase 3 biomarker validation of GALAD for the detection of #HepatocellularCarcinoma in #Cirrhosis ⬇️
ow.ly/h6YJ50XfeEk
ow.ly/h6YJ50XfeEk
Our editors were excited to meet the young researchers from Beijing Friendship Hospital who have been translating select Gastroenterology abstracts to share on Chinese social media. Thank you to this team and Prof. Haiyun Shi for all of their efforts!
@alisonkimphd.bsky.social
@alisonkimphd.bsky.social
October 23, 2025 at 4:31 PM
Our editors were excited to meet the young researchers from Beijing Friendship Hospital who have been translating select Gastroenterology abstracts to share on Chinese social media. Thank you to this team and Prof. Haiyun Shi for all of their efforts!
@alisonkimphd.bsky.social
@alisonkimphd.bsky.social
💸 Article reports the costs and quality of life outcomes from the BOSS trial and models the outcomes and cost-effectiveness of surveillance beyond the follow-up period of the BOSS study.
Read the full article here: ow.ly/Rb2c50Xf6uA
Read the full article here: ow.ly/Rb2c50Xf6uA
October 22, 2025 at 2:13 PM
💸 Article reports the costs and quality of life outcomes from the BOSS trial and models the outcomes and cost-effectiveness of surveillance beyond the follow-up period of the BOSS study.
Read the full article here: ow.ly/Rb2c50Xf6uA
Read the full article here: ow.ly/Rb2c50Xf6uA
📣 The November issue of #Gastroenterology is now online. Essential reading includes:
📖 A Review article on the use of genetic testing for GI cancers and polyposis
📖 A study on a novel blood-based diagnostic test for #CeliacDisease
📖 ...and more!
🔗 ow.ly/yZ6s50Xf4NO
📖 A Review article on the use of genetic testing for GI cancers and polyposis
📖 A study on a novel blood-based diagnostic test for #CeliacDisease
📖 ...and more!
🔗 ow.ly/yZ6s50Xf4NO
October 20, 2025 at 5:46 PM
📣 The November issue of #Gastroenterology is now online. Essential reading includes:
📖 A Review article on the use of genetic testing for GI cancers and polyposis
📖 A study on a novel blood-based diagnostic test for #CeliacDisease
📖 ...and more!
🔗 ow.ly/yZ6s50Xf4NO
📖 A Review article on the use of genetic testing for GI cancers and polyposis
📖 A study on a novel blood-based diagnostic test for #CeliacDisease
📖 ...and more!
🔗 ow.ly/yZ6s50Xf4NO
For #LiverAwarenessMonth, let's take a look at a study that found adipose tissue macrophage-derived sEVs promote liver fibrosis in obesity via pro-fibrogenic miRNAs.
Read it here: 🔗 ow.ly/Wx9550XcMkB
#LiverFibrosis #MASH #sEVs #miRNAs
Read it here: 🔗 ow.ly/Wx9550XcMkB
#LiverFibrosis #MASH #sEVs #miRNAs
October 17, 2025 at 5:55 PM
For #LiverAwarenessMonth, let's take a look at a study that found adipose tissue macrophage-derived sEVs promote liver fibrosis in obesity via pro-fibrogenic miRNAs.
Read it here: 🔗 ow.ly/Wx9550XcMkB
#LiverFibrosis #MASH #sEVs #miRNAs
Read it here: 🔗 ow.ly/Wx9550XcMkB
#LiverFibrosis #MASH #sEVs #miRNAs
Study finds fidaxomicin reduces collagen expression in intestinal fibroblasts via platelet-derived growth factor receptor beta and glycogen synthase kinase-3 beta inhibition.
🔗 ow.ly/2Gh950XbKch
🔗 ow.ly/2Gh950XbKch
October 15, 2025 at 6:43 PM
Study finds fidaxomicin reduces collagen expression in intestinal fibroblasts via platelet-derived growth factor receptor beta and glycogen synthase kinase-3 beta inhibition.
🔗 ow.ly/2Gh950XbKch
🔗 ow.ly/2Gh950XbKch
Study finds structural variations in ulcerative colitis-associated E. coli reduce fructose utilization and aggravate inflammation under high fructose diet.
🔗 ow.ly/zhUr50X7gMN
🔗 ow.ly/zhUr50X7gMN
October 10, 2025 at 4:26 PM
Study finds structural variations in ulcerative colitis-associated E. coli reduce fructose utilization and aggravate inflammation under high fructose diet.
🔗 ow.ly/zhUr50X7gMN
🔗 ow.ly/zhUr50X7gMN
New #Gastroenterology Clinical Practice Guideline on #gastroparesis management was featured in @medpagetoday.com.
📰 Check out the press coverage: ow.ly/AZXQ50X7jfc
📝 Read the article: ow.ly/uj2150X7jh5
📰 Check out the press coverage: ow.ly/AZXQ50X7jfc
📝 Read the article: ow.ly/uj2150X7jh5
October 9, 2025 at 6:35 PM
New #Gastroenterology Clinical Practice Guideline on #gastroparesis management was featured in @medpagetoday.com.
📰 Check out the press coverage: ow.ly/AZXQ50X7jfc
📝 Read the article: ow.ly/uj2150X7jh5
📰 Check out the press coverage: ow.ly/AZXQ50X7jfc
📝 Read the article: ow.ly/uj2150X7jh5
Review examines pharmacomicrobiomics and the role of the #GutMicrobiome in immunomodulation and cancer therapy. Read the full article here: ow.ly/34GO50X7evW
October 8, 2025 at 4:28 PM
Review examines pharmacomicrobiomics and the role of the #GutMicrobiome in immunomodulation and cancer therapy. Read the full article here: ow.ly/34GO50X7evW
⏪ Let's take a look back at one of the most engaging articles from this past summer — an ERCP review highlighting how the ability to prevent and treat ERCP-related adverse events has improved substantially. Click the link to read the article: ow.ly/3ANV50X7iOH
October 7, 2025 at 4:27 PM
⏪ Let's take a look back at one of the most engaging articles from this past summer — an ERCP review highlighting how the ability to prevent and treat ERCP-related adverse events has improved substantially. Click the link to read the article: ow.ly/3ANV50X7iOH
🌟 Click the link to read the global consensus recommendations for #MASLD and #MASH now!
🔗 ow.ly/fOWQ50X7cFb
🔗 ow.ly/fOWQ50X7cFb
October 6, 2025 at 4:35 PM
🌟 Click the link to read the global consensus recommendations for #MASLD and #MASH now!
🔗 ow.ly/fOWQ50X7cFb
🔗 ow.ly/fOWQ50X7cFb
🔥Hot paper by junior investigators examines inadequate propulsion and pelvic floor relaxation in dyssynergic defecation. Click the link to learn more insights from synchronous proctomanometry:
🔗 ow.ly/oMFU50X3CLU
🔗 ow.ly/oMFU50X3CLU
October 3, 2025 at 6:40 PM
🔥Hot paper by junior investigators examines inadequate propulsion and pelvic floor relaxation in dyssynergic defecation. Click the link to learn more insights from synchronous proctomanometry:
🔗 ow.ly/oMFU50X3CLU
🔗 ow.ly/oMFU50X3CLU
Study finds tumor necrosis factor-like ligand 1A/death receptor 3 signaling regulates the generation of pathogenic T helper 9 cells in experimental #CrohnsDisease. Read more at ow.ly/1tXA50X3Cf1
#IntestinalInflammation
#IntestinalInflammation
October 1, 2025 at 4:32 PM
Study finds tumor necrosis factor-like ligand 1A/death receptor 3 signaling regulates the generation of pathogenic T helper 9 cells in experimental #CrohnsDisease. Read more at ow.ly/1tXA50X3Cf1
#IntestinalInflammation
#IntestinalInflammation